Introduction to “Screening for Endocrine Activity—Experiences with the US EPA's Endocrine Disruptor Screening Program and Future Considerations”

Abstract

Birth Defects Research Part B: Developmental and Reproductive ToxicologyVolume 101, Issue 1 p. 1-2 Introduction Introduction to “Screening for Endocrine Activity—Experiences with the US EPA's Endocrine Disruptor Screening Program and Future Considerations” Sue Marty, Corresponding Author Sue Marty Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, MichiganCorrespondence to: Dr. Sue Marty, The Dow Chemical Company, 1803 Building, Midland, MI 48674. E-mail: mmarty@dow.comSearch for more papers by this author Sue Marty, Corresponding Author Sue Marty Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, MichiganCorrespondence to: Dr. Sue Marty, The Dow Chemical Company, 1803 Building, Midland, MI 48674. E-mail: mmarty@dow.comSearch for more papers by this author First published: 07 February 2014 https://doi.org/10.1002/bdrb.21100Citations: 3Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume101, Issue1Special Issue: Screening for Endocrine Activity – Experiences with the US EPA's Endocrine Disruptor Screening Program and Future ConsiderationsFebruary 2014Pages 1-2 RelatedInformation